Crosstree

(redirected from Crosstrees)
Also found in: Dictionary, Wikipedia.

Crosstree

 

a wood or steel structure serving to connect the parts of the vertical spars of a sailing ship, for instance, to connect the topgallant mast to the topmast. It is usually a frame made of longitudinal beams (trestletrees) and transverse beams (crosspieces). Crosstrees are used for fastening shrouds, other standing rigging, and parts of the cargo handling equipment, as well as for mounting crow’s nests.

Mentioned in ?
References in periodicals archive ?
Devices using Crosstrees Pod technology feature a polymer material constructed to control the delivery of PMMA (polymethylmethacrylate) bone cement to the fracture site.
based Crosstrees is developing and commercializing a product portfolio that addresses the demand for improved vertebral fracture treatment.
We must recall also that Joyce decided to retain the word crosstree even after Budgen, who was a sailor, informed him that the proper word was yard.
Crosstrees has developed a portfolio of issued patents in the United States, EU, China, and Taiwan, with additional applications pending for a broad portfolio of therapeutic devices and methods of use.
The Great Lie by Myrrha Stanford-Smith The docks were still for once, the incessant hammering silenced as he rode, weary and saddle-sore through Deptford to Crosstrees, Fearghas cantering at his side.
Research and Development staff at Crosstrees developed the patented technology to address the need for improved vertebral fracture repair devices that can potentially reduce risk of complications in vertebral augmentation procedures, such as nerve root compression, pulmonary embolism, and arterial embolism, reported in the published literature.
The Crosstrees Pod(TM) System offers performance benefits that may significantly improve surgical outcomes for patients with vertebral fractures," said Robert Scribner, President & CEO of Crosstrees Medical, Inc.
The Crosstrees Pod(TM) System offers multiple opportunities for improved surgical outcomes for patients with degenerative spine conditions," said Robert Scribner, President & CEO of Crosstrees Medical, Inc.
In the USA, the Crosstrees Pod(TM) System is being evaluated in an IDE clinical study being conducted in support of a future 510(k) market clearance submission to the U.
Lieberman is a paid consultant to Kyphon, he is a paid consultant and owns stock or has stock options in Crosstrees, Merlot OrthopediX, Trans1, Axiomed, Mazor Surgical, and he receives royalties from DePuy Spine and Stryker Spine.
After all, a yard is also a crosstree for the on-looking landlubber.